Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Steroid | 1 | 2025 | 26 | 0.230 |
Why?
|
| Antiviral Agents | 1 | 2025 | 112 | 0.220 |
Why?
|
| Immunity, Innate | 1 | 2025 | 226 | 0.200 |
Why?
|
| Nitro Compounds | 1 | 2020 | 10 | 0.170 |
Why?
|
| Benzopyrans | 1 | 2020 | 22 | 0.170 |
Why?
|
| Dimethylallyltranstransferase | 1 | 2020 | 5 | 0.170 |
Why?
|
| Streptomyces | 1 | 2020 | 11 | 0.170 |
Why?
|
| Indoles | 1 | 2020 | 99 | 0.160 |
Why?
|
| Rheology | 1 | 2019 | 22 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 121 | 0.150 |
Why?
|
| Bioprinting | 1 | 2019 | 9 | 0.150 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 37 | 0.150 |
Why?
|
| Hydrogels | 1 | 2019 | 58 | 0.150 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 95 | 0.140 |
Why?
|
| Ampicillin | 1 | 2016 | 14 | 0.130 |
Why?
|
| Polyethyleneimine | 1 | 2016 | 18 | 0.130 |
Why?
|
| Aspergillus | 1 | 2015 | 9 | 0.120 |
Why?
|
| Fungi | 1 | 2015 | 57 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 679 | 0.110 |
Why?
|
| Sulfonamides | 2 | 2020 | 73 | 0.110 |
Why?
|
| Azo Compounds | 1 | 2013 | 5 | 0.100 |
Why?
|
| Nanowires | 1 | 2013 | 5 | 0.100 |
Why?
|
| Photochemical Processes | 1 | 2013 | 15 | 0.100 |
Why?
|
| Bacteriophage M13 | 1 | 2013 | 21 | 0.100 |
Why?
|
| Autocrine Communication | 1 | 2011 | 7 | 0.090 |
Why?
|
| Nanostructures | 1 | 2013 | 64 | 0.090 |
Why?
|
| Bystander Effect | 1 | 2011 | 16 | 0.090 |
Why?
|
| Aldehydes | 1 | 2011 | 55 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2013 | 202 | 0.090 |
Why?
|
| Enterococcus faecalis | 1 | 2011 | 71 | 0.090 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2011 | 91 | 0.090 |
Why?
|
| Colon | 1 | 2011 | 121 | 0.090 |
Why?
|
| DNA Damage | 1 | 2011 | 151 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2011 | 248 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2020 | 180 | 0.080 |
Why?
|
| Lantana | 1 | 2009 | 2 | 0.080 |
Why?
|
| Lignans | 1 | 2009 | 10 | 0.080 |
Why?
|
| Glycosides | 1 | 2009 | 8 | 0.080 |
Why?
|
| Plants, Medicinal | 1 | 2009 | 18 | 0.080 |
Why?
|
| Macrophages | 1 | 2011 | 295 | 0.080 |
Why?
|
| Hypochlorous Acid | 1 | 2008 | 10 | 0.070 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2008 | 34 | 0.070 |
Why?
|
| Glutathione | 1 | 2008 | 76 | 0.070 |
Why?
|
| Molecular Structure | 3 | 2015 | 243 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2008 | 174 | 0.060 |
Why?
|
| Animals | 4 | 2025 | 10423 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2020 | 151 | 0.060 |
Why?
|
| Virus Replication | 1 | 2025 | 65 | 0.060 |
Why?
|
| Kinetics | 2 | 2020 | 545 | 0.050 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2015 | 55 | 0.050 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 30 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2020 | 60 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2020 | 67 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 103 | 0.040 |
Why?
|
| Prenylation | 1 | 2020 | 3 | 0.040 |
Why?
|
| Naphthols | 1 | 2020 | 6 | 0.040 |
Why?
|
| Alkylation | 1 | 2020 | 18 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2020 | 22 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2020 | 222 | 0.040 |
Why?
|
| Ink | 1 | 2019 | 3 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 13 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2019 | 23 | 0.040 |
Why?
|
| Viscosity | 1 | 2019 | 38 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 521 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 551 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 409 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 806 | 0.030 |
Why?
|
| Mice | 2 | 2020 | 4654 | 0.030 |
Why?
|
| Oxidation-Reduction | 2 | 2008 | 365 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 775 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 1319 | 0.030 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2016 | 9 | 0.030 |
Why?
|
| Teichoic Acids | 1 | 2016 | 18 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 104 | 0.030 |
Why?
|
| Vancomycin | 1 | 2016 | 58 | 0.030 |
Why?
|
| Cell Wall | 1 | 2016 | 67 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 148 | 0.030 |
Why?
|
| Indole Alkaloids | 1 | 2015 | 9 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2015 | 30 | 0.030 |
Why?
|
| Deuterium | 1 | 2015 | 50 | 0.030 |
Why?
|
| Humans | 3 | 2025 | 28097 | 0.030 |
Why?
|
| Metabolome | 1 | 2015 | 68 | 0.030 |
Why?
|
| Biological Products | 1 | 2015 | 65 | 0.030 |
Why?
|
| Capsid Proteins | 1 | 2013 | 12 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2013 | 45 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2013 | 36 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 132 | 0.020 |
Why?
|
| Stathmin | 1 | 2011 | 2 | 0.020 |
Why?
|
| Tetraploidy | 1 | 2011 | 2 | 0.020 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2011 | 5 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 33 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 53 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 55 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 524 | 0.020 |
Why?
|
| Spindle Apparatus | 1 | 2011 | 52 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 137 | 0.020 |
Why?
|
| Histones | 1 | 2011 | 95 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 72 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 206 | 0.020 |
Why?
|
| Transfection | 1 | 2011 | 318 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 138 | 0.020 |
Why?
|
| Caffeic Acids | 1 | 2009 | 3 | 0.020 |
Why?
|
| Glucosides | 1 | 2009 | 8 | 0.020 |
Why?
|
| Phytotherapy | 1 | 2009 | 22 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 848 | 0.020 |
Why?
|
| Catalysis | 1 | 2008 | 133 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 267 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1592 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 191 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2008 | 452 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 1461 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2008 | 668 | 0.010 |
Why?
|